Brief: Natco Pharma To Launch Semaglutide In India In March 2026
25/02/2026 04:38
Feb 25 (Reuters) - Natco Pharma Ltd NATP.NS: NATCO PHARMA - COMPANY TO LAUNCH SEMAGLUTIDE IN INDIA IN MARCH 2026 Source text: ID:nBSE4rCg7D Further company coverage: NATP.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees